Yixiang Mao

1.1k total citations
24 papers, 751 citations indexed

About

Yixiang Mao is a scholar working on Oncology, Molecular Biology and Immunology. According to data from OpenAlex, Yixiang Mao has authored 24 papers receiving a total of 751 indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Oncology, 8 papers in Molecular Biology and 8 papers in Immunology. Recurrent topics in Yixiang Mao's work include Immunotherapy and Immune Responses (6 papers), Cancer Immunotherapy and Biomarkers (5 papers) and Pancreatic and Hepatic Oncology Research (4 papers). Yixiang Mao is often cited by papers focused on Immunotherapy and Immune Responses (6 papers), Cancer Immunotherapy and Biomarkers (5 papers) and Pancreatic and Hepatic Oncology Research (4 papers). Yixiang Mao collaborates with scholars based in China, United States and Egypt. Yixiang Mao's co-authors include Kai Chen, Min Tao, Wei Li, Xiaoyan Jia, Weiming Duan, Ping Chang, Donghui Li, Min Tao, Yun Dai and Yufeng Xie and has published in prestigious journals such as Scientific Reports, Biochemical and Biophysical Research Communications and Journal of Cellular Biochemistry.

In The Last Decade

Yixiang Mao

24 papers receiving 743 citations

Peers

Yixiang Mao
Hye Won Chung South Korea
Chunhui Zhang China
Vera Balz Germany
Sofia Spyridonidou Greece
José Manuel Cózar Spain
Xiaoqin Yang China
Kan Wu China
Amanda Mikels‐Vigdal United States
Rong‐Miao Zhou China
Luis A. Martinez United States
Hye Won Chung South Korea
Yixiang Mao
Citations per year, relative to Yixiang Mao Yixiang Mao (= 1×) peers Hye Won Chung

Countries citing papers authored by Yixiang Mao

Since Specialization
Citations

This map shows the geographic impact of Yixiang Mao's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yixiang Mao with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yixiang Mao more than expected).

Fields of papers citing papers by Yixiang Mao

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yixiang Mao. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yixiang Mao. The network helps show where Yixiang Mao may publish in the future.

Co-authorship network of co-authors of Yixiang Mao

This figure shows the co-authorship network connecting the top 25 collaborators of Yixiang Mao. A scholar is included among the top collaborators of Yixiang Mao based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yixiang Mao. Yixiang Mao is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Mao, Yixiang, et al.. (2025). Cross study transcriptomic investigation of Alzheimer’s brain tissue discoveries and limitations. Scientific Reports. 15(1). 16041–16041. 1 indexed citations
2.
3.
Luo, Yang, Wěi Li, Zefei Jiang, et al.. (2019). Pharmacokinetics of pertuzumab administered concurrently with trastuzumab in Chinese patients with HER2-positive early breast cancer. Anti-Cancer Drugs. 30(8). 866–872. 3 indexed citations
4.
Chen, Weiwei, Weiwei Xu, Jixiang Wu, et al.. (2018). BLACAT1 predicts poor prognosis and serves as oncogenic lncRNA in small‐cell lung cancer. Journal of Cellular Biochemistry. 120(2). 2540–2546. 38 indexed citations
5.
Mao, Yixiang, Jianjun Shen, Yue Lu, et al.. (2017). RNA sequencing analyses reveal novel differentially expressed genes and pathways in pancreatic cancer. Oncotarget. 8(26). 42537–42547. 46 indexed citations
6.
Xu, Hong, Xiaoling Chen, Min Tao, et al.. (2016). B7-H3 and B7-H4 are independent predictors of a poor prognosis in patients with pancreatic cancer. Oncology Letters. 11(3). 1841–1846. 43 indexed citations
7.
Xia, Zuguang, Xiaoyan Jia, Kai Chen, et al.. (2016). Survival benefits from postoperative radiation therapy on lymph node positive patients with pancreatic adenocarcinoma. Oncotarget. 7(29). 46646–46652. 1 indexed citations
8.
Mao, Yixiang, Min Tao, Xiaoyan Jia, et al.. (2015). Effect of Diabetes Mellitus on Survival in Patients with Pancreatic Cancer: A Systematic Review and Meta-analysis. Scientific Reports. 5(1). 17102–17102. 43 indexed citations
9.
Xu, Hong, Zuguang Xia, Xiaoyan Jia, et al.. (2015). Primary Tumor Resection Is Associated with Improved Survival in Stage IV Colorectal Cancer: An Instrumental Variable Analysis. Scientific Reports. 5(1). 16516–16516. 33 indexed citations
10.
Xie, Xin, Mengyao Wu, Liu‐Mei Shou, et al.. (2014). Tamoxifen enhances the anticancer effect of cantharidin and norcantharidin in pancreatic cancer cell lines through inhibition of the protein kinase C signaling pathway. Oncology Letters. 9(2). 837–844. 23 indexed citations
11.
Mao, Yixiang, Wei Li, Kai Chen, et al.. (2014). B7-H1 and B7-H3 are independent predictors of poor prognosis in patients with non-small cell lung cancer. Oncotarget. 6(5). 3452–3461. 108 indexed citations
12.
Shou, Liu‐Mei, Qiongyan Zhang, Wei Li, et al.. (2013). Cantharidin and norcantharidin inhibit the ability of MCF-7 cells to adhere to platelets via protein kinase C pathway-dependent downregulation of α2 integrin. Oncology Reports. 30(3). 1059–1066. 54 indexed citations
13.
Lian, Lian, Wei Li, Zhenyu Li, et al.. (2012). Inhibition of MCF-7 breast cancer cell-induced platelet aggregation using a combination of antiplatelet drugs. Oncology Letters. 5(2). 675–680. 47 indexed citations
14.
Zhang, Sheng, Wenfeng Li, Zuguang Xia, & Yixiang Mao. (2011). CD4 T cell dependent tumor immunity stimulated by dendritic cell based vaccine. Biochemical and Biophysical Research Communications. 413(2). 294–298. 6 indexed citations
15.
Dai, Haiyan, Peng Wang, Lanyun Feng, et al.. (2010). The Molecular Mechanisms of Traditional Chinese Medicine ZHENG Syndromes on Pancreatic Tumor Growth. Integrative Cancer Therapies. 9(3). 291–297. 14 indexed citations
16.
Chen, Xiaoling, et al.. (2009). Expression of B7-H1 protein in human pancreatic carcinoma tissues and its clinical significance. Chinese Journal of Cancer. 28(12). 1328–1332. 23 indexed citations
17.
18.
Xu, Hong, Yixiang Mao, Xueguang Zhang, & Qingcai Wang. (2008). [Influence of intravenous chemotherapy on cellular immunity in patients with advanced digestive tract cancer].. PubMed. 27(4). 418–24. 3 indexed citations
19.
Mao, Yixiang, Yongjing Chen, Yan Ge, et al.. (2006). Recombinant human B7-H4 expressed in Escherichia coli inhibits T lymphocyte proliferation and IL-2 secretion in vitro1. Acta Pharmacologica Sinica. 27(6). 741–746. 10 indexed citations
20.
Wang, Tian‐Li, et al.. (2004). [Biological effects of soluble CD40 ligand on lung cancer cell line A549 and its mechanism].. PubMed. 23(11). 1278–82. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Hye Won Chung Breakdown of academic impact, for papers by Chunhui Zhang Breakdown of academic impact, for papers by Vera Balz Breakdown of academic impact, for papers by Sofia Spyridonidou Breakdown of academic impact, for papers by José Manuel Cózar Breakdown of academic impact, for papers by Xiaoqin Yang Breakdown of academic impact, for papers by Kan Wu Breakdown of academic impact, for papers by Amanda Mikels‐Vigdal Breakdown of academic impact, for papers by Rong‐Miao Zhou Breakdown of academic impact, for papers by Luis A. Martinez
Rankless by CCL
2026